Supernus Pharmaceuticals Inc. (SUPN)

37.20
0.22 0.59
NASDAQ : Health Technology
Prev Close 36.98
Open 37.98
Day Low/High 37.06 / 38.00
52 Wk Low/High 34.90 / 61.25
Volume 445.34K
Avg Volume 582.40K
Exchange NASDAQ
Shares Outstanding 52.26M
Market Cap 1.98B
EPS 1.10
P/E Ratio 20.72
Div & Yield N.A. (N.A)

Latest News

First Week Of November 16th Options Trading For Supernus Pharmaceuticals (SUPN)

First Week Of November 16th Options Trading For Supernus Pharmaceuticals (SUPN)

Investors in Supernus Pharmaceuticals Inc saw new options become available this week, for the November 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SUPN options chain for the new November 16th contracts and identified one put and one call contract of particular interest.

First Week Of October 19th Options Trading For Supernus Pharmaceuticals (SUPN)

First Week Of October 19th Options Trading For Supernus Pharmaceuticals (SUPN)

Investors in Supernus Pharmaceuticals Inc saw new options begin trading this week, for the October 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SUPN options chain for the new October 19th contracts and identified one put and one call contract of particular interest.

More Tax Reform Winners

More Tax Reform Winners

One way or another I continue to believe that some sort of tax legislation will be signed before the end of the year.

CVS Health, Coca-Cola, Norfolk Southern: 'Mad Money' Lightning Round

CVS Health, Coca-Cola, Norfolk Southern: 'Mad Money' Lightning Round

Jim Cramer is bullish on CVS Health, Coca-Cola, Norfolk Southern, IBM and Randgold Resources.

Victory Comes From Leadership: Cramer's 'Mad Money' Recap (Thursday 11/9/17)

Victory Comes From Leadership: Cramer's 'Mad Money' Recap (Thursday 11/9/17)

Jim Cramer says that whether it's at West Point or on Wall Street, leadership comes from loyalty, innovation, and the first-mover advantage.

MediWound Shares Lower After Pricing Stock Offering - Biotech Movers

MediWound Shares Lower After Pricing Stock Offering - Biotech Movers

MediWound priced an underwritten public offering of 4.4 million shares at $5 apiece.

Supernus Defeats Second Generic Challenger To Oxtellar XR®

Supernus Defeats Second Generic Challenger To Oxtellar XR®

Federal Court Finds Supernus Patents Valid and Infringed by TWi

UPS, McKesson, Chegg and More: 'Mad Money' Lightning Round

UPS, McKesson, Chegg and More: 'Mad Money' Lightning Round

Here's a look at what Jim Cramer had to say about companies of interest to Mad Money viewers.

Investors Should Ignore Washington: Cramer's 'Mad Money' Recap (Tuesday 7/18/17)

Investors Should Ignore Washington: Cramer's 'Mad Money' Recap (Tuesday 7/18/17)

Investors need to focus on earnings and not be distracted by the circus in Washington, Jim Cramer says.

10 Sectors That Will Profit Big-Time From Oil's Crash

10 Sectors That Will Profit Big-Time From Oil's Crash

Oil prices are tumbling down. Bad news for companies and petro states, but great news at the pump and for these ten industries...

Biotech Movers: Anika Up on Strong Analyst Ratings

Biotech Movers: Anika Up on Strong Analyst Ratings

Anika focuses on pain management, tissue regeneration and wound healing.

TheStreet Quant Rating: B (Buy)